Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.05 USD | +3.54% | +8.47% | -12.77% |
09/05 | Transcript : Xeris Biopharma Holdings, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
09/05 | Earnings Flash (XERS) XERIS BIOPHARMA HOLDINGS Reports Q1 Revenue $40.6M, vs. Street Est of $41.8M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.77% | 29Cr | |
+34.35% | 69TCr | |
+29.39% | 58TCr | |
-3.49% | 37TCr | |
+20.15% | 33TCr | |
+6.19% | 29TCr | |
+14.11% | 24TCr | |
-3.03% | 21TCr | |
+10.02% | 21TCr | |
+9.21% | 17TCr |
- Stock Market
- Equities
- XERS Stock
- News Xeris Biopharma Holdings, Inc.
- SVB Leerink Adjusts Xeris Biopharma Holdings Price Target to $6 From $8, Maintains Outperform Rating